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Various psychostimulants targeting monoamine neurotransmitter transporters (MATs)
have been shown to rescue cognition in patients with neurological disorders and
improve cognitive abilities in healthy subjects at low doses. Here, we examined the
effects upon cognition of a chemically synthesized novel MAT inhibiting compound
2-(benzhydrylsulfinylmethyl)-4-methylthiazole (named as CE-104). The efficacy of CE-
104 in blocking MAT [dopamine transporter (DAT), serotonin transporter (SERT), and
norepinephrine transporter] was determined using in vitro neurotransmitter uptake
assay. The effect of the drug at low doses (1 and 10 mg/kg) on spatial memory was
studied in male rats in the radial arm maze (RAM). Furthermore, the dopamine receptor
and transporter complex levels of frontal cortex (FC) tissue of trained and untrained
animals treated either with the drug or vehicle were quantified on blue native PAGE
(BN-PAGE). The drug inhibited dopamine (IC50: 27.88 µM) and norepinephrine uptake
(IC50: 160.40 µM), but had a negligible effect on SERT. In the RAM, both drug-dose
groups improved spatial working memory during the performance phase of RAM as
compared to vehicle. BN-PAGE Western blot quantification of dopamine receptor and
transporter complexes revealed that D1, D2, D3, and DAT complexes were modulated
due to training and by drug effects. The drug’s ability to block DAT and its influence on
DAT and receptor complex levels in the FC is proposed as a possible mechanism for
the observed learning and memory enhancement in the RAM.
Keywords: CE-104, cognitive enhancement, dopamine uptake inhibitor, monoamine neurotransmitter uptake
inhibitor, radial arm maze, dopamine receptor complexes, dopamine transporter complexes
INTRODUCTION
Psychostimulants are a class of psychoactive compounds that have diverse behavioral effects such
as increasing arousal, alertness and motivation, altering mood, facilitating working, and long
term memories. It can improve cognition in patients with cognitive disabilities caused by various
psychiatric illnesses like Alzheimer disease, attention deficit hyperactivity disorder (ADHD), or
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schizophrenia (Goodman and Gilman, 2006; Berridge and
Devilbiss, 2011). Basic research and clinical trials show that these
compounds improve performance in cognitive challenging tasks
also in healthy subjects (Husain and Mehta, 2011).
The majority of these compounds inhibit monoamine
neurotransmitter transporters (MATs) which reuptake the
released neurotransmitters back into the presynaptic nerve
terminal (Kristensen et al., 2011), thus induce an increase of
extracellular monoamine neurotransmitter (MNT) levels and
related subsequent signaling (Berridge and Devilbiss, 2011).
Moreover, this class of drug specifically targets MAT of prefrontal
cortex (PFC) regions, which are largely implicated in mediating
complex executive cognitive functions (Spencer et al., 2012). The
resulting elevated levels of monoamines in the PFC are associated
with improved cognition (Berridge and Devilbiss, 2011). Other
mechanism includes activation of MNT receptors or candidate
targets of the downstream signaling pathway, increasing the
oxygen and glucose supply to the nerve cells (Froestl et al., 2012,
2014a,b).
A number of MAT inhibitors have been documented to be
effective in various cognitive tasks. For instance, modafinil that
inhibits dopamine reuptake in the synapse has been shown to
improve spatial memory in the multiple T-maze (Sase et al.,
2012) and in the Morris water maze (Shuman et al., 2009; Tsanov
et al., 2010). However, the actions of modafinil are diverse in
different learning paradigms. It specifically improves the working
memory but not the spatial reference memory in rats tested
in radial arm maze (RAM; Sase et al., 2012). In delayed non-
matching to position task in the water maze, 55 and 100 mg/kg
made significantly more correct choices, the latter said dose
enhanced the locomotor activity, but with no efficient goal-
directed behavior in the rats (Ward et al., 2004). In spatial serial
discrimination (reversal task; Béracochéa et al., 2002, 2003) and
in delayed spontaneous alteration in T-maze (Béracochéa et al.,
2001) modafinil had effect only in high dose of 64 mg/kg but had
no effect in relatively low clinically relevant doses. In contextual
serial discrimination task performed in mice using hole board
apparatus, modafinil 32 but not a 16 mg/kg dose enhanced the
successful discriminations, whereas it had no effect in spatial
serial discrimination task (Béracochéa et al., 2008). In other
paradigms, five-choice serial reaction time task, that tests the
attention (Waters et al., 2005) and in object recognition task
(Garcia et al., 2013) modafinil did not had any effects in any of
the doses tested.
Amphetamines which are a diverse group of compounds that
block MAT with different specificities are distinct in their mode
of action compared to other psychostimulants (Fleckenstein
et al., 2007). Although competitive inhibitors of MAT, they
can exert their actions in other ways as (a) they are taken up
by the plasma-membrane MAT as exogenous substrates (Sitte
et al., 1998), (b) induce eﬄux of monoamines by aiding the
release of neurotransmitter vesicles (Partilla et al., 2006), and
(c) act by MAT reverse transport mechanism (Robertson et al.,
2009). The latter said effect is predominant in magnitude in
amphetamine’s psychostimulant effects (Sitte and Freissmuth,
2015). In doses less than 0.05 mg/kg in rats, amphetamine
enhanced the freezing reaction in a cued fear conditioning
paradigm whereas at the same dose it had no effect on a
contextual fear conditioning test. In contrast, modafinil had
opposite actions in fear conditioning tests, increasing contextual
memory whereas cued related memory remains unaffected
(Shuman et al., 2009; Shanmugasundaram et al., 2015a). Thus,
these drugs can produce different effects in learning and memory
tasks based on the nature of cognitive tasks, the dosage, MAT
blocking profile and activation of drug specific various other
cellular targets.
In order to overcome these heterogeneous effects, to eliminate
abuse potentials and also to reduce the adverse effects, attempts
are still being made to develop novel drugs targeting MAT to
increase the effects upon cognitive function in healthy subjects
and to treat mental disorders. New drugs should also meet
the demands of increased specificity of the effects on cognitive
performance possibly with no or least side effects. Therefore,
a novel heterocyclic compound was chemically synthesized by
replacing the amide group of modafinil with a heterocyclic
group. The MNT reuptake blocking capability was studied using
in vitro uptake assays and effects on cognition were tested in
rats in a RAM spatial memory paradigm. The task demands the
establishment of a complex learning strategy involving WM and
the PFC to successfully find the reward with minimal efforts
(Vertes, 2006). Further, the dopamine receptor complexes (RCs)
and total DAT as well as phosphorylated DAT (DAT-ph) complex
levels in the frontal cortex (FC) tissue of animals trained in the
RAM with drug or vehicle were also quantified and compared
with controls.
MATERIALS AND METHODS
Chemical Synthesis of CE-104
CE-104 was chemically synthesized by following a modified
procedure used for the synthesis of modafinil (Courvoisier
et al., 2012). The general scheme of the synthesis is shown in
Supplementary Figure S1. The structure representing modafinil
was converted to appropriate thioamide by Lawesson’s reagent.
The obtained product was converted to the methylthiazole analog
with chloromethyl ketone in Hantsch-like synthesis. The final
compound was obtained in the racemic form by oxidation of
sulfur with 30% H2O2 in glacial acetic acid.
The step by step synthesis procedure is described in the
Supplementary Material.
Monoamine Neurotransmitter Uptake
Assay
The following materials were purchased from companies;
Dulbecco’s modified Eagle’s medium (DMEM) and trypsin
from PAA Laboratories GmbH (Pasching, Austria). Fetal
bovine serum was from Invitrogen. [3H]5-HT ([3H]5-
hydroxytryptamine; [3H]serotonin; 28.3 µCi/mmol) and
[3H]DA ([3H]dihydroxyphenylethylamine; [3H]dopamine;
46 µCi/mmol) were from Perkin Elmer, Boston, MA, USA.
[3H]1-Methyl-4-phenylpyridinium ([3H]MPP+; 85 µCi/mmol)
was supplied by American Radiolabeled Chemicals (St. Louis,
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MO, USA). Paroxetine from Santa Cruz Biotechnology, USA,
and mazindole and D-amphetamine from Sigma-Aldrich, Co.
HEK293 cells stably expressing human isoforms of DAT,
serotonin transporter (SERT) and norepinephrine transporter
(NET) named as HEK-DAT, HEK-SERT, and HEK-NET
respectively were used for this purpose. Effects of CE-104 on
uptake of their respective substrates were analyzed as described
by (Sucic et al. (2010)). In brief, the cells were grown in poly-
d-lysine coated 96-well plates in DMEM containing 10% fetal
bovine serum. CE-104 was dissolved first in 100% dimethyl
sulfoxide (DMSO) and subsequently diluted in Krebs–Ringer–
HEPES buffer (KHB; 25 mM HEPES.NaOH, pH 7.4, 120 mM
NaCl, 5 mM KCl, 1.2 mM CaCl2, and 1.2 mM MgSO4
supplemented with 5 mM D-glucose). To determine unspecific
uptake, 10 µM of mazindole were used in HEK-DAT and
HEK-NET cells and 10 µM of paroxetine was used for HEK-
SERT. The titrated substrates used to assess transport activity in
HEK-DAT, HEK-SERT, and HEK-NET were 0.2 µM [3H]DA,
0.4 µM [3H]5HT, and 0.05 µM [3H]MPP+, respectively. The
cells were washed once with KHB buffer and incubated with
CE-104 either 5 min for HEK-DAT and HEK-SERT cells or
8 min for HEK-NET cells. Subsequently, the substrates were
added and incubated for 1 min for HEK-DAT and HEK-
SERT cells or 3 min for HEK-NET cells and reactions were
stopped with ice-cold KHB buffer. The cells were harvested using
trypsin and lysed with 1% SDS and released radioactivity was
measured by a liquid scintillation counter (Tri-carb-2300TR,
Perkin Elmer).
Radial Arm Maze
Animals
Seventy two male Sprague Dawley rats, aged between 12 and
14 weeks, were used for the experiments. They were bred and
maintained in cages made of Makrolon filled with autoclaved
woodchips in the Core Unit of Biomedical Research, Division
of Laboratory Animal Science and Genetics, Medical University
of Vienna. Food and water in bottles were available ad libitum
and reared under normal animal facility conditions (temperature:
22± 2◦C; humidity: 55± 5%; 12 h artificial light/12 h dark cycle:
light on at 7:00 am). The behavioral experiments were conducted
between 8:00 am and 2:00 pm. All procedures were carried out
according to the guidelines of the Ethics committee, Medical
University of Vienna, and were approved by Federal Ministry of
Education, Science and Culture, Austria (BMWFW-66.009/0114-
WF/II/3b/2014).
Apparatus
The RAM setup is made of black plastic and kept at an elevation
of 80 cm above the floor in a room with numerous visual cues
placed distally on all sides. The central platform had a diameter
of 50 cm with 12 arms (12 cm × 60 cm) projecting radially
outward. A plastic cylinder placed in the center was used to
restrict the movement of rats before the start of the training.
The lifting of the cylinder is controlled by a pulley system from
the far end of the room. Food is always placed 5 cm from the
distal end of the arm. The training sessions were recorded with
a computerized tracking video camcorder (1/3 SSAM HR EX
VIEW HAD).
Drug Administration
CE-104 was freshly dissolved in DMSO and injected everyday
30 min before the start of the behavior experiment throughout
the training and performance sessions. Pure DMSO was used
as vehicle. Rats received 1 ml/kg drug or vehicle administered
intraperitoneally in doses of 1 and 10 mg/kg body weight.
The Training Procedure
Radial arm maze training was performed using a modified
protocol as described by Levin et al. (2010). The amount of food
provided was restricted for 5 days prior to the experiment to
reduce the body weight to 85% to motivate the rats for foraging
behavior during the training sessions. Water was provided ad
libitum throughout the entire training procedure. The rats were
handled for 30 min/day during these 5 days for adaptation to the
experimenter. Two days before the start of the actual training,
rats were given habituation session for 5 min in which some
food pellets were placed scattered all over the maze and rats were
allowed to explore the maze and let consume the food. During
the training sessions, out of 12 arms, eight arms were baited
only once at the beginning of each session and the remaining
four were kept unbaited. The pattern of baited and unbaited
arms remained unchanged throughout the entire procedure for
each rat but differed among rats. Each trial began by placing
the rat in the central platform, after 10 s the cylinder was
slowly lifted. A session lasts 8 min or until all eight baited arms
were entered. The rats were given one training session per day
over a period of 10 days. The first entry into an unbaited arm
was noted as a reference memory error (RME), second and
subsequent entries into unbaited arms were counted as a working
memory error (WME-unbaited), second and subsequent entry
into the baited arm was noted as working memory error (WME-
baited). The time taken to complete a trial was also recorded as
latency.
Untrained animals (yoked) were exposed to the maze and
spatial cues for same amount of time as their trained counterparts
but without reward, therefore rats did not learn to associate the
cues with the reward.
Blue Native-Polyacrylamide Gel
Electrophoresis (BN-PAGE)
Six hours after the last session of RAM training on day 10, the
animals were sacrificed after anaesthetizing them with CO2. The
brain was quickly extracted and was kept on a cold plate and the
FC was cut 3 mm from the anterior end after removing olfactory
bulb by a chilled razor blade. The tissues were immediately frozen
in dry ice and were stored at −80◦C. Only the 10 mg/kg dose
group was used for biochemical studies.
Sample Preparation
Crude synaptosome fractions were prepared from the FC as
described previously (Shanmugasundaram et al., 2015b). The
samples were maintained at 4◦C throughout the procedure.
In brief, the FC tissues were homogenized in 5 ml of ice
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cold homogenization buffer containing 10 mM HEPES, pH
7.7, 300 mM sucrose, 1 mM EDTA, protease inhibitor cocktail
(Roche Diagnostics, Mannheim, Germany) using Ultra-Turrax R©
(IKA, Staufen, Germany). The homogenate was centrifuged
for 10 min at 1000 × g and the pellet was discarded. The
supernatant was centrifuged at 50,000 × g for 30 min using an
ultracentrifuge (Beckman Coulter Optima-L-90K). The pellet was
re-suspended in washing buffer (homogenization buffer without
sucrose), kept on ice for 1 h and centrifuged at 50,000 × g
for 30 min to obtain membrane fractions of crude synaptosome
extracts.
The synaptosome membrane pellets were solubilized in
extraction buffer (1.5 M 6-aminocaproic acid, 300 mM Bis-
Tris, pH 7.0) containing 1% Triton X-100 with vortexing every
10 min for 1 h. Following solubilization, samples were cleared
by centrifugation at 20,000 × g for 60 min at 4◦C. The protein
content of the supernatant was estimated using the BCA protein
assay kit (Pierce, Rockford, IL, USA). Extracted proteins were
then aliquoted and stored at−80◦C.
BN-PAGE Western Blot Procedure
Equal amounts of proteins (70 µg) from all groups were loaded
in the wells and the RCs were separated on 5–13% of blue native
PAGE gels and the Western blot procedure was carried out using
the procedure described previously (Kang et al., 2009). The details
of antibodies used are as follows; D1R (1:5000, Abcam-ab81296,
Cambridge, UK), D2R (1:5000, Abcam-ab21218, Cambridge,
UK), D3R (1:5000, Abcam-ab42114, Cambridge, UK), pDAT
(1:5000, DAT Thr53, Phosphosolutions-p435-53, Aurora, CO,
USA) and DAT (1:5000, Abcam- ab111468, Cambridge, UK)
and detected with horseradish peroxidase-conjugated anti-rabbit
IgG secondary antibody (1:10000, Abcam-ab6721, Cambridge,
UK). Immunoreactive bands were quantified by the software
Image J (NIH). Coomassie blue R-350 stained membranes were
used as loading control and normalized with the Western blot
densitometric values (Welinder and Ekblad, 2011; Sase et al.,
2012).
Statistical Analysis
Non-linear regression analysis was carried out to determine the
IC50 values for uptake assays. The effect of training and the
effect of drug on learning performance in RAM were analyzed
using two-way ANOVA (with Bonferroni adjustments) with
drug effects and training effects as the two factors performed
on the dependent variables WME-baited, WME-unbaited, RME
and latency. For day-by-day analysis to compare the drug
effects, pairwise multiple comparison was done using univariate
analysis with LSD post hoc test. The densitometry values of BN-
PAGE Western blot quantification were compared using two-way
ANOVA (training X drug) with LSD post hoc test for multiple
comparison to reveal the differences between groups vehicle-
trained, CE-104-trained, vehicle-yoked and CE-104-yoked. The
probability level of p < 0.05 was considered as statistically
significant. Regression analysis was done using GraphPad Prism
(version 6.00, GraphPad Software, San Diego CA, USA). ANOVA
was performed using SPSS (version 20.0; SPSS, Inc., Chicago,
IL, USA).
RESULTS
CE-104 Blocks DAT with Modest and
NET with Lower Affinity
The efficacy of CE-104 to block the DAT, SERT, and NET
from the uptake of their respective substrates [3H]DA, [3H]5HT,
and [3H]MPP+ was determined. Figure 1 shows that CE-104
blocks DAT with IC50 = 27.88 ± 0.104 µM (n = 9) while
the effect on NET was IC50 = 160.40 ± 0.09561 µM (n = 9).
In case of SERT the CE-104 blockade effects were negligible
(IC50:∼955009± 440.4 µM; n= 9).
CE-104 Improves Working Memory
Performance in RAM
The total number of WME-baited, WME-unbaited, RME and
latency to finish a session by the animals during the training
and performance sessions were shown in Figure 2. In the two-
way ANOVA analysis, due to the effect of training the vehicle,
1 and 10 mg/kg groups showed significant decrease of WME-
baited during the learning F(4,145) = 9.823, p < 0.0001 and in
the performance sessions F(4,145)= 5.927, p< 0.0001. The RME
significantly declined in the training phase F(2,150) = 4.867,
p < 0.005 and in the performance phase F(2,145) = 21.756,
p < 0.0001. The latency to finish a session was also declined
significantly during the learning F(4,150) = 7.762, p < 0.001
and in the performance phase F(4,150) = 21.645, p < 0.001.
The drug treatment had significant effect on RME, during the
training phase F(4,150)= 9.482, p< 0.0001, WME-baited during
the performance phase F(2,145) = 8.848, p < 0.0001, WME-
unbaited during the performance phase F(2,145) = 21.756,
p < 0.0001 and latency during the training F(2,150) = 10.585,
FIGURE 1 | Evaluation of monoamine neurotransmitter transporter
blockade of CE-104: inhibition of dopamine and norepinephrine
transport by CE-104 in HEK293 cells stably expressing human
isoforms of DAT, SERT, and NET. CE-104 inhibited dopamine uptake with
IC50 of 27.88 ± 0.104 µM (n = 9) and norepinephrine uptake with IC50 of
160.40 ± 0.09561 µM (n = 9). Inhibition of SERT was negligible (IC50:
∼955009 ± 440.4 µM).
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FIGURE 2 | (A) Working memory error (WME)-baited reduced significantly due to repeated training (p < 0.0001) and were significantly decreased in drug treated
group on days-8, 9, and 10 compared to vehicle. (B) WME-unbaited were significantly decreased in drug treated group on days-7, 8, 9, and 10 compared to
vehicle. (C) RME (Reference memory error) reduced significantly with the respect to training sessions (p < 0.01). (D) Latency to complete the task declined
significantly during the training and performance sessions (p < 0.001). Mean and SEM are shown in the graph. The data were analyzed using two-way ANOVA with
Bonferroni post hoc adjustments for within subject effects. Day-by-day comparison was performed using univariate analysis with LSD adjustments. x – vehicle vs.
1 mg/kg, y – vehicle vs. 10 mg/kg (∗p < 0.05; ∗∗p < 0.01; #p < 0.005).
p < 0.001 and the performance phase F(2,150) = 23.985,
p < 0.001.
Day-by-day analysis comparing vehicle and drug treated
groups revealed that in the performance phase of RAM, WME-
baited were significantly decreased in both 1 and 10 mg/kg
drug treated groups on day-8 (vehicle vs. 1 mg/kg: p < 0.05),
day-9 (vehicle vs. 1 mg/kg: p < 0.05, vehicle vs. 10 mg/kg:
p < 0.05), and day-10 (vehicle vs. 1 mg/kg: p = 0.018, vehicle
vs. 10 mg/kg: p < 0.05). WME-unbaited significantly decreased
in both, 1 and 10 mg/kg drug treated groups on day-7 (vehicle
vs. 1 mg/kg: p < 0.05), day-8 (vehicle vs. 1 mg/kg: p < 0.05,
vehicle vs. 10 mg/kg: p < 0.05), day-9 (vehicle vs. 1 mg/kg:
p < 0.005, vehicle vs. 10 mg/kg: p < 0.005), and day-10
(vehicle vs. 1 mg/kg: p < 0.01, vehicle vs. 10 mg/kg: p < 0.01)
compared to vehicle. RME increased in 1 mg/kg group on
day-2 (vehicle vs. 1 mg/kg, p < 0.05). The latency decreased
significantly on day-3 (vehicle vs. 10 mg/kg: p < 0.05) and
day-5 (vehicle vs. 1 mg/kg: p < 0.01) in the training session
and also during performance session on day-8 (vehicle vs.
1 mg/kg: p < 0.005) and on day-9 (vehicle vs. 10 mg/kg:
p < 0.005).
The F ratios and p values of the one way repeated
measure ANOVA statistical analysis was shown in the
Table 1.
Training and CE-104 Modulates Synaptic
Dopamine Receptors D1, D2, and D3
Levels
Two-way ANOVA analysis of BN-PAGE Western blot
densitometric values of dopamine RCs were shown in Figure 3.
Multiple comparisons using LSD post hoc test revealed differences
between the groups.
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TABLE 1 | Showing the statistical F ratios and p values of two way ANOVA analysis of training and performance sessions of RAM.
Independent variables Learning sessions Effect of training Effect of drug treatment
Multiple comparison
Vehicle vs.
1 mg/kg
Vehicle vs.
10 mg/kg
WME-baited Training F (4,145) = 9.823, p < 0.0001 F (2,145) = 0.692, p = 0.502 – –
Performance F (4,145) = 5.927, p < 0.0001 F (2,145) = 8.848, p < 0.0001 p < 0.0001 p < 0.05
WME-unbaited Training F (4,145) = 0.532, p = 0.712 F (2,145) = 1.965, p = 0.144 – –
Performance F (4,145) = 1.192, p = 0.317 F (2,145) = 21.756, p < 0.0001 p < 0.0001 p < 0.0001
RME Training F (2,150) = 4.867, p < 0.005 F (4,150) = 9.482, p < 0.0001 p < 0.01 –
Performance F (2,145) = 21.756, p < 0.0001 F (4,145) = 1.192, p = 0.317 – –
Latency Training F (4,150) = 7.762, p < 0.001 F (2,150) = 10.585, p < 0.001 p < 0.001 p < 0.001
Performance F (4,150) = 21.645, p < 0.001 F (2,150) = 23.985, p < 0.001 p < 0.001 p < 0.001
For the D1 receptor which was separated at 600 kDa: in
drug injected groups, D1∼600 kDa containing complex levels
were increased significantly in trained groups compared to yoked
groups (p < 0.005) whereas there was no significant change
in vehicle groups. For the D2 receptor which was separated at
600 kDa: in the vehicle treated group D2∼600 kDa containing
complex levels were significantly lowered in trained animals
(p < 0.01) whereas, there were no changes in the drug-treated
group and the levels were significantly decreased in drug-treated
animals compared to vehicle in yoked groups (p < 0.01). For the
D3 receptor which was separated at 600 kDa: in vehicle treated
groups D3∼600 kDa containing complex levels were decreased
significantly in trained animals compared to the yoked groups
(p < 0.05).
The F ratios and p values of the two way repeated measure
ANOVA statistical analysis were shown in the Table 2.
CE-104 Modulates Synaptic Dopamine
Transporter Levels
Two-way ANOVA analysis of BN-PAGE Western blot
densitometric comparison of DAT complexes were shown
in Figure 4. For total DAT which was separated at 720 kDa:
in the yoked group, DAT∼720 kDa containing complex levels
were significantly increased in the drug-treated group compared
to vehicle (p < 0.05) and in the DAT∼600 kDa containing
complex levels were significantly decreased in the trained
animals compared to yoked in the vehicle treated groups
(p < 0.05).
DISCUSSION
The animals had learned the spatial memory task which is evident
from the gradually decreasing WME, RME and latency due to
repeated training in the RAM. In order to retrieve the food
effectively in the RAM paradigm, rats have to avoid re-visits of
arms, which involves WM (Mizumori et al., 1987). Application
of CE-104 improved the spatial working but not the reference
memory during performance sessions as revealed by less WME
in the drug treated rats as compared to controls. Both doses
of CE-104 exert similar behavioral effect with no dose-response
differences.
From various electrophysiological recordings (Chafee and
Goldman-Rakic, 1998), lesioning (Granon et al., 1994; van
Asselen et al., 2006), and functional neuroimaging (D’Esposito
et al., 2000; Fletcher and Henson, 2001) studies it is evident
that the PFC is specifically involved in the processing of
WM mechanisms. Low dose psychostimulants generally exert
regionally restricted actions elevating extracellular monoamine
levels preferentially in the PFC and eventually facilitating
neurotransmitter mediated signal processing (Berridge and
Devilbiss, 2011). A study revealed that direct infusion of
methylphenidate (0.5 µg/500 nl) into the dorsal anterior
cingulate/dorsal prelimbic subfields of the medial PFC of rats
improves spatial WM performance, comparable to that seen
with systemic administration (Spencer et al., 2012). Many such
cognitive enhancers inhibit MAT – DAT, SERT, and NET
selectively or promiscuously (Berridge and Devilbiss, 2011).
The uptake assays revealed that CE-104 blocks DAT rather
specifically at 28 µM, suggesting the involvement of dopamine
in the improvement of the spatial WM in RAM. Importantly,
dopamine afferents within the PFC display a greater sensitivity to
a variety of environmental and pharmacologic challenges relative
to the subcortical dopamine systems (Roth et al., 1988; Berridge
et al., 1999). Other MAT blockers like indeloxazine blocked the
reuptake of norepinephrine with an IC50 of 3.2 µM (CE-104 at
160 µM) and reuptake of serotonin with an IC50 of 0.71 µM
(CE-104 negligible effects) and also enhanced the memory in
a variety of tests paradigms in the brain regions in a specific
monoamine-concentration dependent manner (Yamaguchi et al.,
1996).
Measuring monoamine concentrations with in vivo
microdialysis in rats performing a delayed alternation task in
presence of low and clinically relevant doses of methylphenidate
revealed increased norepinephrine and dopamine eﬄux within
the PFC region but not in the nucleus accumbens and the
medial septal area; WM was significantly improved while
locomotion and electroencephalographic–electromyographic
indices of arousal were only minimally affected (Berridge
et al., 2006). This may support the low-dose induced specific
Frontiers in Behavioral Neuroscience | www.frontiersin.org 6 February 2016 | Volume 10 | Article 20
fnbeh-10-00020 February 18, 2016 Time: 20:34 # 7
Aher et al. CE-104 Enhances Spatial Working Memory
FIGURE 3 | Representative blot of BN-PAGE Western quantification of dopamine receptor complexes in frontal cortex tissue. D1∼600 kDa,
D2∼600 kDa, and D3∼600 kDa receptor complexes were modulated as a result of training and drug treatment. Graph shows mean ± SD. Special characters
indicate level of significance of difference in two-way ANOVA (∗p < 0.05; ∗∗p < 0.01; #p < 0.005).
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enhancement of PFC-dependent cognitive functions without
deterioration of the general behavioral organization. The
similarity of behavioral effects in the presence of both low doses
of CE-104 in our study suggests an appropriate safety margin of
CE-104.
We have shown previously that several neurotransmitter RCs
rather than receptor subunits, including dopamine receptors are
modulated due to training in spatial memory paradigms like
multiple T-maze and Barnes maze (Ghafari et al., 2011; Keihan
Falsafi et al., 2012). The changes in levels of dopamine RCs and
DAT complexes we reported here could be associated with the
persistent chemical changes of the neuronal synapses as a result of
RAM training and due to the chronic effect of the drug treatment
as we did the biochemical analysis after completion of training
sessions.
In trained drug-treated animals, D1 receptor containing
complexes were significantly elevated when compared to yoked
animals suggesting a training induced up-regulation of D1
receptor levels. We can exclude a mere drug induced or a
solely training induced modulation since no differences in D1
RCs levels between the related groups could be observed. The
involvement of FC D1 receptors in WM mechanism is already
well documented. Stimulation of dopamine D1 receptors in
the PFC can improve spatial WM related cognitive deficits
and may even enhance cognitive function in healthy animals
(Mehta and Riedel, 2006). The cognition-enhancing actions
CE-104 could be due to the drug-induced enhanced signaling
of D1 receptors in the PFC. Consistent with this hypothesis,
the ability of low-dose methylphenidate to improve PFC-
dependent behavior is hindered by systemically administered
D1 antagonists, as measured in delayed-response tasks. These
observations infer that the cognition-enhancing effects of
low-dose psychostimulants are dependent on D1 receptors
located within the PFC (Berridge and Devilbiss, 2011).
Additional evidence also suggests a prominent role of PFC
D1 receptors in the behavioral and electrophysiological
actions of low-dose psychostimulants (Berridge et al.,
2012).
The D2 and D3 receptor containing complex levels were
down-regulated due to training which could be observed only
in vehicle treated group and not in drug treated group.
The dopamine D1 but not D3 receptor plays a fundamental
role in spatial WM in PFC of mice (Xing et al., 2012),
however mice lacking both D2 and D3 receptors have spatial
WM deficits (Glickstein et al., 2002). Our results show
that the drug down-regulates D2 receptor levels in drug
treated animals compared to vehicle group only in untrained
animals. These results indicate a differential requirement
of D1, D2, and D3 receptor levels in the synapse in
mediating the effects of CE-104 on spatial WM and cognitive
function.
The DAT is a plasma membrane-spanning protein known
to mediate uptake of released dopamine from the extracellular
space into the pre-synaptic neuron, thereby maintaining
homeostasis. The cell surface expression and its activity
are mainly regulated by post-translational modification and
binding partner interaction (Vaughan and Foster, 2013). Total
DAT complex levels were significantly increased in drug
treated groups compared to vehicle in the yoked animals.
This signifies that CE-104 not only acts pharmacologically
but also alters the DAT levels in the synapse. To support
this interpretation, substantial evidence defends that the
chronic use of several psychostimulant drug alters the DAT
levels as well as its activity, but its mechanisms are not
known (Schmitt and Reith, 2010). However, levels of total
DAT in trained animals were comparable between CE-
104 administered and vehicle treated groups. Regulation
of DAT activity by phosphorylation at Thr53 plays an
important role in modulating its function (Foster et al.,
2012). Intriguingly, the levels of phosphorylated DAT were
comparable between groups. This could be due to a long-term
adaptive response by the dopaminergic system (particularly in
synaptic active DAT-ph levels) to the drug induced increase
in extracellular dopamine concentrations during learning and
plasticity.
CE-104’s ability to inhibit the DAT and its regulation of
dopamine receptor and transporter complex levels could be
a possible mechanism for its behavioral effects in the RAM.
DAT reuptake inhibition is in the order of magnitude as for
modafinil and so are cognitive enhancing effects of CE-104 and
modafinil at low doses (Karabacak et al., 2015). In addition,
the use of more doses are recommended in further studies as
modafinil type cognitive enhancers were shown to have diverse
and different effects ranging from 0.1 mg/kg body weight up
to 120 mg/kg body weight. The cognitive neuromodulators
of the DAT inhibition exerts its function in a complex way
TABLE 2 | Showing the statistical F ratios and p values of the two way ANOVA of the Western blot quantification of the receptor complexes in BN-PAGE.
Receptor complex Training effect Drug effect Interaction
D1R ∼600 kDa F (1,36) = 11.76, p < 0.005 F (1,36) = 1.731, p = 0.1966 F (1,36) = 1.101, p = 0.3011
D2R ∼720 kDa F (1,35) = 0.03396, p = 0.8549 F (1,35) = 3.494, p = 0.0700 F (1,35) = 2.822, p = 0.1019
D2R ∼600 kDa F (1,35) = 0.3112, p = 0.5805 F (1,35) = 1.722, p = 0.1979 F (1,35) = 11.27, p < 0.005
D3R ∼720 kDa F (1,36) = 4.926, p < 0.05 F (1,36) = 0.1426, p = 0.7080 F (1,36) = 0.3582, p = 0.5532
D3R ∼600 kDa F (1,35) = 8.868, p < 0.001 F (1,35) = 0.9438, p = 0.3380 F (1,35) = 0.07993, p = 0.7791
DAT ∼720 kDa F (1,36) = 1.777, p = 0.1909 F (1,36) = 4.794, p < 0.05 F (1,36) = 1.718, p = 0.1982
DAT ∼600 kDa F (1,35) = 5.487, p < 0.05 F (1,35) = 0.2377, p = 0.6289 F (1,35) = 0.9620, p = 0.3334
DAT-ph ∼720 kDa F (1,35) = 1.802, p = 0.1881 F (1,35) = 0.3607, p = 0.5520 F (1,35) = 0.8845, p = 0.3534
DAT-ph ∼600 kDa F (1,35) = 4.033, p = 0.0524 F (1,35) = 1.343, p = 0.2544 F (1,35) = 0.2286, p = 0.6356
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FIGURE 4 | Representative blot of BN-PAGE Western quantification of dopamine transporter complexes in frontal cortex tissue. DAT∼720 kDa
complex levels were increased due to drug treatment in yoked animals. No differences in phosphorylated DAT Thr53 (DAT-ph) complex levels were found. Graph
shows mean ± SD, special characters denote level of significance of difference in two-way ANOVA (∗p < 0.05).
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(Minzenberg and Carter, 2008; Qu et al., 2008; Spiller et al.,
2013) and further behavioral, pharmacokinetic, neurotoxicity,
and molecular studies in several brain areas are required
to reveal the specific mechanistic actions and adverse effects
of CE-104.
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